Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…e and fludarabine, followed by a single intravenous infusion of rapcabtagene autoleucel, with the initial three dosed sequentially with a 28-day observ…
…1 year follow-up 181/289 (62.6%) RSV-patients received systemic ATB. More prescribed were fluoroquinolones (33.2%), amoxicillin/bet…
…ts. Mono and co-cultures were exposed to the ER stress inducers tunicamycin, subtilase cytotoxin (SubAB) and HA-15. Cells were also treated…
… of 22.2 months (95% CI 18.1-26.2), 51% of patients interrupted nintedanib due to diarrhoea (33%), nausea/vomiting (21%), reflux (2%), wei…
…rature review (2024) suggests that intravenous immunoglobulins (IVIG) may offer significant therapeutic benefit in gastrointestinal …
…ith less social avoidance due to nausea, suggesting that better MeDi adherence may alleviate certain gastrointestinal-related qualit…
…. The mean disease duration was 7.4±6.4 years. All pts received prednisolone at mean dose of 10±4 mg/day. 11% of patients received cyclophos…
… disease duration, SSc subtype, and ILD indicated a doubling of PRO-C6 was associated FVC worsening, with a hazard ratio (HR) of 1.91 …
… anti-acids (proton pump inhibitors, H2 blockers), antibiotics, calcium channel blockers, NSAIDs and pain killers. No significant differences between SS…
…ease presented with subacute hearing loss. Her medications were fluoxetine, Domperidone, cholecalciferol, omeprazole, sildenafil, Pregabal…
…polymerase III (POLR3), fibrillarin, NOR-90, Th/To, PM/Scl, Ku, Ro52), a commercial ELISA (anti-U1RNP), and a custom ELISA (anti-RNP…
…ess common (14.3% vs 55.3%, p=0.05). Compared with anti-Scl-70, anti-U11/U12RNP patients showed lower prevalence of Raynaud’s phenomenon (78.6%…